# FDA releases 14 drug rejection letters after 3-month pause

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-13 21:29 UTC · Category: Business · Sources: 5 · Current Velocity: 2.8

## Executive Summary
FDA resumes releasing drug rejection letters after 3-month pause

## Intelligence Brief
The FDA has released 14 new drug rejection letters, ending a three-month pause.


Coverage emphasizes the FDA's return to transparency in drug development, with multiple outlets reporting on the release of the letters. Sources including Fierce Biotech, Endpoints News, and BioSpace note the significance of the FDA's move.


The FDA's pause and subsequent release of rejection letters have sparked interest in the pharmaceutical industry, with some outlets speculating about potential court challenges related to the FDA's disclosure policies.

## Verified Facts & Key Claims
### What is the FDA releasing?
Drug rejection letters

### How many letters were released?
14

### What was the duration of the pause?
3 months

## Key People, Organizations & Locations
FDA, Development, ACT Brief FDA CRL Transparency Pause Protocol-Centric Recruitment Model Shift and Medical Affairs Integration, FDA's CRL Disclosure Freeze and DTC Ad Crackdown Likely Headed for Court Sue Sutter and Derrick Gingery Warn

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Applied Clinical Trials Online | ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development | 2026-07-13 15:01 | [Source Link](https://news.google.com/rss/articles/CBMi1AFBVV95cUxOZlpkNVZXdl9aU3FFaThFc3FjaFF6a1ByYy1QU3BaV2RWMTE5NEhEY25yY2FVNUV2TjZZWXlKem91RS1XVmszQkdzUVpISGxTa3FVWEE4RW9uVlpYaWtkRGtrNUpfc21hWWplMEp3c0l5LXZGRVkwN2drN1lkQzBnOEVZemprSUxnZW1YbGl3MWFNNFJnZlIyTXFHWE9MTEtuekx0WVBIWFpCQUtTMkxRenZna2lOZU5DV3VEc3U0bkxwcVB0dUlDUWtZY0YzNEVkZ28zWA?oc=5) |
| finance.biggo.com | FDA's CRL Disclosure Freeze and DTC Ad Crackdown Likely Headed for Court, Sue Sutter and Derrick Gingery Warn | 2026-07-13 15:01 | [Source Link](https://news.google.com/rss/articles/CBMiW0FVX3lxTFBxbm83UW9CaGRPTW1rLTFieXVQQjJMOHBfUXIzaEJCdFpPWDBsZ1E4NHdjRkdmU3FXUldPSzBjMzlUV19uNFo3NUFTRk1sdkhwbzZoMllGZ1pTeXc?oc=5) |
| BioSpace | FDA posts new rejection letters days after confirming pause | 2026-07-13 15:01 | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxQbEZLaWV3NFgybUhBbFJjNVlSTV9YSFc1RUhaaE9aZGptYUxBcjdwOEpTNDZQeTNuaVRIOV96YTdvckRibVUtSlhhMnZlSXFPa2piV3dGQ083MjBoVk1yT1d5SkN1ZHdhYjhRaWlkdzNXbV9iWkZFQkdSS3VpSU9qWEJHdHdFN3dGaEtxY0xOUEtPdw?oc=5) |
| Endpoints News | FDA returns to releasing pharma rejection letters with 14 new CRLs | 2026-07-13 15:01 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxPdzdoZ2pTdFg2QkVCNW5oNXR6MGhvWjhuYWpsWEpUUEdBaXdEMklpZnRPcjZVWGNtYklUT1hveloxejVXX0NjRUZ6blFPT0FiWWZIZ2w2eHY3WEZaeVlhQ29BVlFZREwycW92ZDcyNjRMMms0SW5CRUFEZ1RLV1lLX0w4REJVMnpCQTR1VHJDTGlXU1dZ?oc=5) |
| Fierce Biotech | FDA releases 14 drug rejection letters after 3-month pause | 2026-07-13 15:01 | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxNU1NuTnJDa1I1a3JPTHp0QjFZOUxtTUQzSGVISndyMDZlZkVOSDhIdGxvQnZCWWNhREN3SmU2ckdzZEFUanY5M1c0OUY4VFY0Zi00SlNvLXhJUDh0djhCSTdqeXplN0NMaU9DTTVWTG82YnNxMDNnMXVDTEFTUVVpSjNoTWotVnlYdTFUM09MR0hocS1ING9aWlFWY3Z3Y25YOTJqWTFiTkVlZWNSMTVicm9FdnJfeXJDNWU0?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-13/fda-releases-14-drug-rejection-letters-after-3-month-pause*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*